Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. BeyondSpring Inc leads the sector with a market cap of $61.27 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
BeyondSpring Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 751 |
BeyondSpring Inc
NASDAQ:BYSI |
$61.27 Million | $61.27 Million | USA | $1.65 | +5.10% | -3.51% | 581.38K |
| 752 |
ImmunoPrecise Antibodies Ltd.
NASDAQ:HYFT |
$61.17 Million | $61.17 Million | USA | $1.56 | +0.00% | -7.14% | 12.84 Million |
| 753 |
Cingulate Inc
NASDAQ:CING |
$60.40 Million | $60.40 Million | USA | $4.93 | +1.02% | +9.68% | 18.15 Million |
| 754 |
FLUOGUIDE A/S DK -1
F:96X |
$60.33 Million | €51.60 Million | Germany | €3.96 | +3.39% | +2.06% | 0.00 |
| 755 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT |
$59.95 Million | $59.95 Million | USA | $6.72 | +8.56% | -4.00% | 5.59 Million |
| 756 |
Ikena Oncology Inc
NASDAQ:IKNA |
$59.90 Million | $59.90 Million | USA | $1.43 | +4.38% | +13.49% | 8.91 Million |
| 757 |
OKYO Pharma Ltd ADR
NASDAQ:OKYO |
$59.80 Million | $59.80 Million | USA | $1.59 | -1.85% | -3.64% | 2.23 Million |
| 758 |
ImageneBio, Inc.
NASDAQ:IMA |
$59.67 Million | $59.67 Million | USA | $5.54 | -1.42% | -1.95% | 637.33K |
| 759 |
iBio, Inc. Common Stock
NASDAQ:IBIO |
$59.64 Million | $59.64 Million | USA | $1.65 | -2.37% | -9.34% | 17.13 Million |
| 760 |
NRX Pharmaceuticals Inc
NASDAQ:NRXP |
$58.91 Million | $58.91 Million | USA | $4.08 | +6.25% | -1.45% | 39.42 Million |
| 761 |
Filana Therapeutics, Inc.
NASDAQ:FLNA |
$58.45 Million | $58.45 Million | USA | $1.21 | -3.20% | -8.33% | 8.71 Million |
| 762 |
Synthaverse S.A.
WAR:SVE |
$58.28 Million | zł211.78 Million | Poland | zł2.80 | +1.64% | +5.87% | 1.53 Million |
| 763 |
Cassava Sciences Inc
NASDAQ:SAVA |
$58.21 Million | $58.21 Million | USA | $1.21 | -6.23% | -20.98% | 10.03 Million |
| 764 |
Arovella Therapeutics Ltd
AU:ALA |
$58.16 Million | AU$82.20 Million | Australia | AU$0.07 | +1.49% | -4.23% | 17.83 Million |
| 765 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
$58.04 Million | $58.04 Million | USA | $0.95 | +4.21% | -3.22% | 11.41 Million |
| 766 |
Paradigm Biopharmaceuticals Ltd
AU:PAR |
$57.63 Million | AU$81.45 Million | Australia | AU$0.16 | +3.33% | +3.33% | 42.18 Million |
| 767 |
Herantis Pharma Oyj
HE:HRTIS |
$57.25 Million | €48.97 Million | Finland | €1.90 | -1.14% | +1.06% | 932.66K |
| 768 |
Cantargia AB
ST:CANTA |
$57.20 Million | Skr531.53 Million | Sweden | Skr2.14 | -1.02% | +0.85% | 48.53 Million |
| 769 |
PDS Biotechnology Corp
NASDAQ:PDSB |
$56.93 Million | $56.93 Million | USA | $1.02 | -2.86% | +0.00% | 27.43 Million |
| 770 |
Pmv Pharmaceuticals Inc
NASDAQ:PMVP |
$56.40 Million | $56.40 Million | USA | $1.06 | -4.50% | -5.36% | 9.04 Million |
| 771 |
GeneOne Life Science Inc
KO:011000 |
$56.16 Million | ₩82.88 Billion | Korea | ₩914.00 | -0.44% | -15.76% | 284.90 Million |
| 772 |
Entera Bio Ltd
NASDAQ:ENTX |
$55.49 Million | $55.49 Million | USA | $1.21 | -1.63% | +2.54% | 1.67 Million |
| 773 |
iNtRON Biotechnology Inc
KQ:048530 |
$55.27 Million | ₩81.56 Billion | Korea | ₩2580.00 | -0.39% | -3.91% | 6.80 Million |
| 774 |
Seres Therapeutics Inc
NASDAQ:MCRB |
$54.42 Million | $54.42 Million | USA | $5.62 | -1.40% | -15.23% | 1.52 Million |
| 775 |
Instil Bio Inc.
NASDAQ:TIL |
$53.71 Million | $53.71 Million | USA | $7.92 | +0.00% | -1.86% | 606.52K |
| 776 |
Kronos Bio Inc
NASDAQ:KRON |
$53.65 Million | $53.65 Million | USA | $0.88 | +1.49% | +0.00% | 5.27 Million |
| 777 |
Shenzhen CAU Technology Co Ltd
SHE:000004 |
$53.47 Million | CN¥365.37 Million | China | CN¥2.76 | +0.00% | -26.60% | 140.27 Million |
| 778 |
Prescient Therapeutics Ltd
AU:PTX |
$52.82 Million | AU$74.66 Million | Australia | AU$0.07 | +4.41% | -1.39% | 25.78 Million |
| 779 |
CTCBIO Inc
KQ:060590 |
$52.82 Million | ₩77.94 Billion | Korea | ₩3260.00 | +1.88% | -0.46% | 4.03 Million |
| 780 |
Ultimovacs ASA
OL:ULTI |
$52.14 Million | Nkr495.45 Million | Norway | Nkr14.40 | +0.00% | +0.00% | 8.70K |
| 781 |
Mink Therapeutics Inc
NASDAQ:INKT |
$51.82 Million | $51.82 Million | USA | $12.54 | +4.28% | +5.60% | 1.11 Million |
| 782 |
Immutep Limited
F:YP1A |
$51.00 Million | €43.62 Million | Germany | €0.30 | +1.37% | -5.73% | 0.00 |
| 783 |
Klotho Neurosciences, Inc.
NASDAQ:KLTO |
$50.59 Million | $50.59 Million | USA | $0.47 | -10.72% | +13.43% | 161.05 Million |
| 784 |
Immutep Ltd
AU:IMM |
$49.99 Million | AU$70.65 Million | Australia | AU$0.05 | +2.13% | -4.00% | 580.33 Million |
| 785 |
MINDMAZE THERAPEUTICS HOLDING SA
SW:MMTX |
$49.91 Million | CHF39.48 Million | Switzerland | CHF0.25 | -10.38% | -27.18% | 32.95 Million |
| 786 |
Corline Biomedical AB
ST:CLBIO |
$49.75 Million | Skr462.32 Million | Sweden | Skr18.05 | +1.98% | +0.28% | 279.11K |
| 787 |
Cellid Co. Ltd
KQ:299660 |
$49.58 Million | ₩73.17 Billion | Korea | ₩2480.00 | -2.17% | -10.31% | 21.51 Million |
| 788 |
CORESTEM Inc
KQ:166480 |
$49.12 Million | ₩72.49 Billion | Korea | ₩2580.00 | +2.58% | -11.49% | 23.24 Million |
| 789 |
Kala Pharmaceuticals Inc
NASDAQ:KALA |
$49.08 Million | $49.08 Million | USA | $2.64 | +0.38% | +28.16% | 2.23 Million |
| 790 |
AlzeCure Pharma
ST:ALZCUR |
$48.97 Million | Skr455.06 Million | Sweden | Skr3.96 | -7.48% | +193.33% | 26.06 Million |
| 791 |
Mereo BioPharma Group PLC ADR
NASDAQ:MREO |
$48.79 Million | $48.79 Million | USA | $0.31 | -4.60% | -9.50% | 37.78 Million |
| 792 |
Bluebird bio Inc
NASDAQ:BLUE |
$48.67 Million | $48.67 Million | USA | $4.97 | +0.00% | +0.00% | 1.25 Million |
| 793 |
Edesa Biotech Inc
NASDAQ:EDSA |
$48.55 Million | $48.55 Million | USA | $5.94 | +2.41% | +8.79% | 8.00 Million |
| 794 |
Intervacc AB
ST:IVACC |
$48.41 Million | Skr449.87 Million | Sweden | Skr1.32 | -2.22% | +1.85% | 12.69 Million |
| 795 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
$47.96 Million | $47.96 Million | USA | $1.52 | +2.70% | +6.29% | 9.68 Million |
| 796 |
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU |
$47.65 Million | $47.65 Million | USA | $2.05 | +1.49% | +9.04% | 3.54 Million |
| 797 |
PENTIXAPHARM HOLDING N AG
XETRA:PTP |
$46.89 Million | €40.11 Million | Germany | €2.30 | -0.43% | -2.13% | 350.55K |
| 798 |
Sprint Bioscience AB
ST:SPRINT |
$46.78 Million | Skr434.72 Million | Sweden | Skr4.12 | +11.96% | +20.12% | 14.91 Million |
| 799 |
Take Solutions Limited
NSE:TAKE |
$46.70 Million | Rs4.32 Billion | India | Rs29.53 | -0.47% | -0.14% | 8.48 Million |
| 800 |
Dogwood Therapeutics, Inc.
NASDAQ:DWTX |
$46.67 Million | $46.67 Million | USA | $1.57 | +1.95% | +4.67% | 1.61 Million |
| 801 |
IGM Biosciences Inc
NASDAQ:IGMS |
$46.47 Million | $46.47 Million | USA | $1.27 | -2.31% | -0.78% | 12.53 Million |
| 802 |
LAVA Therapeutics NV
NASDAQ:LVTX |
$45.77 Million | $45.77 Million | USA | $1.74 | +0.00% | -3.87% | 2.49 Million |
| 803 |
Theranexus SA
PA:ALTHX |
$45.64 Million | €39.03 Million | France | €3.21 | +0.47% | +1.75% | 2.29 Million |
| 804 |
Impact BioMedical, Inc.
NYSE MKT:IBO |
$45.54 Million | $45.54 Million | USA | $0.44 | +0.07% | +4.89% | 5.09 Million |
| 805 |
GenMont Biotech Inc
TW:3164 |
$44.44 Million | NT$1.41 Billion | Taiwan | NT$16.40 | +0.31% | -0.61% | 2.46 Million |
| 806 |
Estrella Immunopharma Inc.
NASDAQ:ESLA |
$44.33 Million | $44.33 Million | USA | $1.03 | -2.83% | -9.65% | 857.45K |
| 807 |
Metagenomi, Inc. Common Stock
NASDAQ:MGX |
$44.05 Million | $44.05 Million | USA | $1.17 | -2.50% | -8.59% | 4.39 Million |
| 808 |
Raphas Co. Ltd
KQ:214260 |
$43.93 Million | ₩64.83 Billion | Korea | ₩7710.00 | +4.76% | +8.74% | 860.42K |
| 809 |
PanGen Biotech Inc
KQ:222110 |
$43.85 Million | ₩64.70 Billion | Korea | ₩4795.00 | -0.72% | -4.67% | 2.62 Million |
| 810 |
Cynata Therapeutics Ltd
AU:CYP |
$43.68 Million | AU$61.74 Million | Australia | AU$0.26 | +0.00% | -8.77% | 10.24 Million |
| 811 |
aTyr Pharma, Inc.
NASDAQ:ATYR |
$43.47 Million | $43.47 Million | USA | $0.44 | +0.75% | -5.68% | 98.94 Million |
| 812 |
OS Therapies Incorporated
NYSE MKT:OSTX |
$42.96 Million | $42.96 Million | USA | $1.73 | -4.95% | -7.98% | 19.37 Million |
| 813 |
SMS Lifesciences India Limited
NSE:SMSLIFE |
$42.13 Million | Rs3.90 Billion | India | Rs1288.50 | -6.64% | -3.37% | 65.05K |
| 814 |
Tevogen Bio Holdings Inc.
NASDAQ:TVGN |
$41.96 Million | $41.96 Million | USA | $10.02 | -4.30% | -4.30% | 999.85K |
| 815 |
Nutriband Inc
NASDAQ:NTRB |
$41.45 Million | $41.45 Million | USA | $3.41 | +0.59% | -4.75% | 234.11K |
| 816 |
Amplia Therapeutics Ltd
AU:ATX |
$39.95 Million | AU$56.46 Million | Australia | AU$0.11 | +0.00% | -8.33% | 24.47 Million |
| 817 |
RTA Laboratuvarlari Biyolojik
IS:RTALB |
$39.87 Million | TL1.78 Billion | Turkey | TL3.56 | +0.56% | +3.19% | 2.40 Billion |
| 818 |
Lantern Pharma Inc
NASDAQ:LTRN |
$39.59 Million | $39.59 Million | USA | $3.69 | -4.90% | +2.79% | 7.67 Million |
| 819 |
Abnova Taiwan Corp
TW:4133 |
$39.47 Million | NT$1.25 Billion | Taiwan | NT$20.69 | +0.43% | -3.10% | 4.48 Million |
| 820 |
Hyperion DeFi, Inc.
NASDAQ:HYPD |
$39.26 Million | $39.26 Million | USA | $2.92 | +7.35% | -2.34% | 14.09 Million |
| 821 |
Gossamer Bio Inc
NASDAQ:GOSS |
$38.65 Million | $38.65 Million | USA | $0.17 | +3.09% | -4.57% | 398.18 Million |
| 822 |
CESSATECH A/S DK -20
F:8GN |
$38.64 Million | €33.05 Million | Germany | €2.37 | +1.72% | +10.23% | 0.00 |
| 823 |
LAVA THERAP. B.V. EO-12
F:4PKB |
$38.54 Million | €32.96 Million | Germany | €1.44 | -6.49% | +5.88% | 28.80K |
| 824 |
OKYO PHARMA LTD SP.ADR/65
F:OK10 |
$38.38 Million | €32.83 Million | Germany | €1.36 | +0.00% | +0.00% | 0.00 |
| 825 |
RenovoRx Inc
NASDAQ:RNXT |
$38.29 Million | $38.29 Million | USA | $0.89 | +4.95% | +1.58% | 7.53 Million |
| 826 |
Entropy Neurodynamics Limited
AU:ENP |
$38.10 Million | AU$53.85 Million | Australia | AU$0.03 | +6.45% | +0.00% | 27.04 Million |
| 827 |
Ascelia Pharma AB (publ)
ST:ACE |
$37.96 Million | Skr352.70 Million | Sweden | Skr2.78 | -1.07% | -4.14% | 16.43 Million |
| 828 |
Vivoryon Therapeutics NV
AS:VVY |
$37.91 Million | €32.42 Million | Netherlands | €1.15 | -0.43% | -7.66% | 1.51 Million |
| 829 |
FibroGen Inc
NASDAQ:FGEN |
$37.30 Million | $37.30 Million | USA | $9.22 | -5.05% | +5.98% | 925.11K |
| 830 |
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM |
$37.02 Million | $37.02 Million | USA | $1.18 | +0.00% | -7.81% | 4.49 Million |
| 831 |
Xilio Development Inc
NASDAQ:XLO |
$36.86 Million | $36.86 Million | USA | $8.34 | +0.36% | +8.31% | 1.34 Million |
| 832 |
Veru Inc
NASDAQ:VERU |
$36.76 Million | $36.76 Million | USA | $3.13 | +4.33% | -7.94% | 108.83 Million |
| 833 |
Relief Therapeutics Holding AG
SW:RLF |
$36.33 Million | CHF28.73 Million | Switzerland | CHF2.89 | +0.87% | +3.41% | 379.74K |
| 834 |
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK |
$36.02 Million | $36.02 Million | USA | $1.16 | -4.92% | +49.29% | 827.18 Million |
| 835 |
Generation Bio Co
NASDAQ:GBIO |
$35.98 Million | $35.98 Million | USA | $5.34 | -6.97% | -4.81% | 2.86 Million |
| 836 |
Mural Oncology plc
NASDAQ:MURA |
$35.38 Million | $35.38 Million | USA | $2.04 | +0.00% | +0.49% | 4.99 Million |
| 837 |
Atara Biotherapeutics Inc
NASDAQ:ATRA |
$35.19 Million | $35.19 Million | USA | $9.96 | -4.32% | +0.40% | 4.66 Million |
| 838 |
Mendus AB (publ)
ST:IMMU |
$35.09 Million | Skr326.03 Million | Sweden | Skr5.32 | +4.31% | +4.93% | 675.52K |
| 839 |
NUREXONE BIOLOGIC INC.
F:J90 |
$34.54 Million | €29.55 Million | Germany | €0.32 | -1.83% | -5.87% | 42.00K |
| 840 |
Grace Therapeutics, Inc.
NASDAQ:GRCE |
$34.20 Million | $34.20 Million | USA | $2.21 | +0.45% | -3.91% | 7.13 Million |
| 841 |
Radiopharm Theranostics Limited American Depositary Shares
NASDAQ:RADX |
$34.06 Million | $34.06 Million | USA | $4.45 | +4.22% | +3.01% | 273.26K |
| 842 |
INmune Bio Inc
NASDAQ:INMB |
$34.03 Million | $34.03 Million | USA | $1.28 | +3.23% | +1.59% | 11.66 Million |
| 843 |
Botanix Pharmaceuticals Ltd
AU:BOT |
$33.46 Million | AU$47.30 Million | Australia | AU$0.02 | +4.35% | +9.09% | 325.86 Million |
| 844 |
DNA Biomed Solns
TA:DNA |
$33.35 Million | ILA12.44 Billion | Israel | ILA101.00 | +13.61% | +13.48% | 2.11 Million |
| 845 |
Plus Therapeutics Inc
NASDAQ:PSTV |
$33.28 Million | $33.28 Million | USA | $4.85 | -3.19% | -10.35% | 3.51 Million |
| 846 |
MedMira Inc
V:MIR |
$33.00 Million | CA$45.61 Million | Canada | CA$0.07 | +0.00% | +8.33% | 1.65 Million |
| 847 |
OnKure Therapeutics, Inc.
NASDAQ:OKUR |
$32.79 Million | $32.79 Million | USA | $4.20 | +0.00% | +0.24% | 6.70 Million |
| 848 |
ABVC Biopharma Inc
NASDAQ:ABVC |
$32.76 Million | $32.76 Million | USA | $1.26 | +5.88% | -5.26% | 2.84 Million |
| 849 |
Lipum AB
ST:LIPUM |
$32.76 Million | Skr304.40 Million | Sweden | Skr14.35 | +0.70% | +1.77% | 1.28 Million |
| 850 |
Avecho Biotechnology Ltd
AU:AVE |
$32.52 Million | AU$45.97 Million | Australia | AU$0.01 | +9.09% | +0.00% | 254.21 Million |
| 851 |
NovaBay Pharmaceuticals Inc
NYSE MKT:NBY |
$32.22 Million | $32.22 Million | USA | $1.21 | +4.31% | -13.57% | 3.36 Million |
| 852 |
Molecure S.A.
WAR:MOC |
$32.21 Million | zł117.03 Million | Poland | zł5.68 | -0.35% | -5.80% | 1.04 Million |
| 853 |
Mereo BioPharma Group plc
F:MAH0 |
$31.92 Million | €27.31 Million | Germany | €0.26 | -7.19% | -7.86% | 2.00K |
| 854 |
Mabion S.A.
WAR:MAB |
$31.80 Million | zł115.56 Million | Poland | zł7.15 | -0.28% | -2.05% | 536.45K |
| 855 |
Radiopharm Theranostics Ltd
AU:RAD |
$31.79 Million | AU$44.93 Million | Australia | AU$0.02 | -5.00% | +0.00% | 46.35 Million |
| 856 |
Level Biotechnology
TWO:3118 |
$31.75 Million | NT$1.01 Billion | Taiwan | NT$31.05 | -0.80% | -7.45% | 1.56 Million |
| 857 |
GeneReach Biotechnology
TWO:4171 |
$31.68 Million | NT$1.01 Billion | Taiwan | NT$17.55 | +0.57% | -2.50% | 2.94 Million |
| 858 |
Imugene Ltd
AU:IMU |
$31.55 Million | AU$44.59 Million | Australia | AU$0.11 | +15.38% | +12.90% | 76.89 Million |
| 859 |
Genoway
PA:ALGEN |
$31.09 Million | €26.60 Million | France | €2.44 | +1.67% | -0.41% | 112.14K |
| 860 |
Lisata Therapeutics Inc.
NASDAQ:LSTA |
$30.43 Million | $30.43 Million | USA | $3.45 | -3.09% | +2.99% | 4.56 Million |
| 861 |
Seoulin Bioscience Co.Ltd
KQ:038070 |
$30.27 Million | ₩44.66 Billion | Korea | ₩5060.00 | -1.17% | -2.13% | 4.91 Million |
| 862 |
Jiangsu Wuzhong Industrial Co Ltd
SHG:600200 |
$30.17 Million | CN¥206.16 Million | China | CN¥0.29 | +0.00% | -9.38% | 993.60 Million |
| 863 |
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM |
$30.09 Million | $30.09 Million | USA | $13.85 | -3.18% | -1.07% | 252.16K |
| 864 |
Evaxion Biotech AS
NASDAQ:EVAX |
$30.02 Million | $30.02 Million | USA | $3.60 | -1.10% | +1.41% | 762.38K |
| 865 |
Allakos Inc
NASDAQ:ALLK |
$29.74 Million | $29.74 Million | USA | $0.33 | +0.00% | +0.00% | 725.84K |
| 866 |
Lite Strategy, Inc.
NASDAQ:LITS |
$29.43 Million | $29.43 Million | USA | $0.80 | +8.18% | +6.73% | 11.99 Million |
| 867 |
Karolinska Development AB ser. B
ST:KDEV |
$29.36 Million | Skr272.85 Million | Sweden | Skr0.29 | +0.00% | +0.00% | 14.10 Million |
| 868 |
EyeGene Inc
KQ:185490 |
$29.01 Million | ₩42.80 Billion | Korea | ₩1405.00 | -1.89% | -5.07% | 79.48 Million |
| 869 |
Microbix Biosystems Inc.
TO:MBX |
$28.85 Million | CA$39.88 Million | Canada | CA$0.29 | -3.33% | +7.41% | 1.57 Million |
| 870 |
Dare Bioscience Inc
NASDAQ:DARE |
$28.83 Million | $28.83 Million | USA | $1.98 | -1.98% | +5.32% | 8.23 Million |
| 871 |
Dyadic International Inc
NASDAQ:DYAI |
$28.80 Million | $28.80 Million | USA | $0.80 | +17.04% | +12.10% | 12.28 Million |
| 872 |
Barinthus Biotherapeutics plc
NASDAQ:BRNS |
$28.60 Million | $28.60 Million | USA | $0.70 | +4.38% | +7.42% | 3.05 Million |
| 873 |
SoftOx Solutions AS
OL:SOFTX |
$28.52 Million | Nkr271.07 Million | Norway | Nkr0.11 | +1.80% | -9.13% | 724.74 Million |
| 874 |
WOOJUNG BIO Inc
KQ:215380 |
$27.90 Million | ₩41.18 Billion | Korea | ₩2470.00 | -1.20% | +0.20% | 4.33 Million |
| 875 |
Lyka Labs Limited
NSE:LYKALABS |
$27.72 Million | Rs2.56 Billion | India | Rs71.82 | +3.19% | +12.98% | 1.64 Million |
| 876 |
Aligos Therapeutics Inc
NASDAQ:ALGS |
$27.53 Million | $27.53 Million | USA | $5.11 | -3.22% | +4.07% | 2.78 Million |
| 877 |
Kyntra Bio, Inc.
NASDAQ:KYNB |
$27.53 Million | $27.53 Million | USA | $6.87 | -3.65% | +2.38% | 669.72K |
| 878 |
India Globalization Capital Inc
NYSE MKT:IGC |
$26.91 Million | $26.91 Million | USA | $0.29 | +0.38% | -3.01% | 21.20 Million |
| 879 |
Athira Pharma Inc
NASDAQ:ATHA |
$26.62 Million | $26.62 Million | USA | $7.66 | +10.85% | +25.78% | 1.34 Million |
| 880 |
Cue Biopharma
NASDAQ:CUE |
$26.56 Million | $26.56 Million | USA | $25.80 | +5.18% | -12.42% | 2.43 Million |
| 881 |
Renovaro Biosciences Inc
NASDAQ:RENB |
$26.19 Million | $26.19 Million | USA | $1.13 | -8.87% | -20.42% | 65.34 Million |
| 882 |
LakeShore Biopharma Co., Ltd
NASDAQ:LSB |
$25.84 Million | $25.84 Million | USA | $0.63 | +0.00% | -26.63% | 93.54K |
| 883 |
Avecho Biotechnology Limited
F:OEZ |
$25.76 Million | €22.04 Million | Germany | €0.01 | +0.00% | -14.29% | 0.00 |
| 884 |
Skye Bioscience, Inc. Common Stock
NASDAQ:SKYE |
$25.64 Million | $25.64 Million | USA | $0.73 | -7.31% | -0.48% | 4.55 Million |
| 885 |
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD |
$25.63 Million | $25.63 Million | USA | $1.40 | -0.71% | -1.41% | 2.21 Million |
| 886 |
Pluri Inc.
NASDAQ:PLUR |
$25.10 Million | $25.10 Million | USA | $2.33 | +2.64% | -1.27% | 401.56K |
| 887 |
Tvardi Therapeutics, Inc.
NASDAQ:TVRD |
$25.05 Million | $25.05 Million | USA | $2.67 | +1.14% | -7.61% | 1.24 Million |
| 888 |
Medicenna Therapeutics Corp
TO:MDNA |
$25.04 Million | CA$34.62 Million | Canada | CA$0.42 | -1.19% | -7.78% | 2.69 Million |
| 889 |
iBio, Inc. Common Stock
NYSE MKT:IBIO |
$24.96 Million | $24.96 Million | USA | $1.20 | -6.25% | +0.00% | 31.77 Million |
| 890 |
PolTREG S.A.
WAR:PTG |
$24.64 Million | zł89.54 Million | Poland | zł19.20 | -0.78% | +1.05% | 301.75K |
| 891 |
LISATA THERAP.INC.DL-001
F:8NE |
$24.41 Million | €20.88 Million | Germany | €3.02 | +3.42% | +7.09% | 0.00 |
| 892 |
Kainos Medicine Inc
KQ:284620 |
$24.10 Million | ₩35.56 Billion | Korea | ₩1087.00 | -8.81% | +9.58% | 9.85 Million |
| 893 |
Arch Biopartners Inc
V:ARCH |
$24.08 Million | CA$33.29 Million | Canada | CA$0.49 | -3.92% | +0.00% | 1.01 Million |
| 894 |
Eutilex.Co.Ltd
KQ:263050 |
$23.94 Million | ₩35.32 Billion | Korea | ₩959.00 | +29.95% | +29.59% | 23.44 Million |
| 895 |
Briacell Therapeutics Corp
NASDAQ:BCTX |
$23.84 Million | $23.84 Million | USA | $2.74 | -1.08% | -11.04% | 7.33 Million |
| 896 |
Xbrane Biopharma AB
ST:XBRANE |
$23.73 Million | Skr220.48 Million | Sweden | Skr10.70 | +0.00% | +0.00% | 988.41K |
| 897 |
Sareum Hldgs Plc
LSE:SAR |
$23.47 Million | £17.48 Million | UK | £23.00 | +0.00% | -2.13% | 5.07 Million |
| 898 |
Neuphoria Therapeutics Inc
NASDAQ:NEUP |
$23.13 Million | $23.13 Million | USA | $4.29 | -1.83% | -4.45% | 1.56 Million |
| 899 |
SynCore Biotechnology Co Ltd
TWO:4192 |
$23.10 Million | NT$733.19 Million | Taiwan | NT$20.85 | -0.95% | +0.72% | 426.54K |
| 900 |
Longeveron LLC
NASDAQ:LGVN |
$23.07 Million | $23.07 Million | USA | $0.79 | +0.89% | +8.22% | 8.54 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries